November 6 – 9, 2019
Baltimore Convention Center, Baltimore, MD
Booth 2749
Corporate Workshop, Wednesday November 6, 2019 REGISTER
Baltimore Convention Center
Room 342
1:00 – 1:50PM
Using Single-cell Genomics and Multi-omics to Unravel Clonal Architecture and Treatment Resistant Mechanisms with Simultaneous Detection of Genotypes and Phenotypes
Where single-cell sequencing methods have improved our ability to better characterize tumor heterogeneity, current modalities are unable to determine both genotype and phenotype from the same cell simultaneously. Discover how the Tapestri Platform enables co-detection of SNVs, CNVs and proteins from the same cell using a single workflow, providing a true multi-omics approach for deeper insight into systems biology and patterns of tumor evolution, therapy response, and resistance. Also join us for a discussion on future multi-omic capabilities.
Welcome and Introduction
Darrin Crisitello, Chief Commercial Officer, Mission Bio
In pursuit of the leukemic stem cell: leveraging single cell genomics and proteomics to identify drivers of AML
Katherine D Cummins, MD FRACP FRCPA, Lab of Saar Gill, MD PhD, University of Pennsylvania
Investigation of AML clonal architecture with mutational and immunophenotypic profiling simultaneously from the same cell(s)
Linde Miles, PhD, Lab of Ross L. Levine, MD, Memorial Sloan Kettering Cancer Center
Expo, Thursday November 7 to Saturday November 9, 2019
Baltimore Convention Center
Booth 2749
Exhibit Hall Dates and Hours
Date | Time |
Thursday, November 7, 2019 | 11:30am – 4:30pm |
Friday, November 8, 2019 | 9:00am – 4:00pm |
Saturday, November 9, 2019 | 9:00am – 1:30pm |